Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes

por Gibbons, Catherine, Blundell, John, Tetens Hoff, Søren, Dahl, Kirsten, Bauer, Robert, Bækdal, Tine
Publicado en Diabetes Obes Metab (2020)

Ex vivo mRNA expression of toll-like receptors during latent tuberculosis infection

por Alemnew, Birhan, Hoff, Soren T., Abebe, Tamrat, Abebe, Markos, Aseffa, Abraham, Howe, Rawleigh, Wassie, Liya
Publicado en BMC Immunol (2021)

Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes

por Dahl, Kirsten, Brooks, Ashley, Almazedi, Firas, Hoff, Søren Tetens, Boschini, Cristina, Bækdal, Tine A.
Publicado en Diabetes Obes Metab (2021)

Randomised Clinical Trial Investigating the Specificity of a Novel Skin Test (C-Tb) for Diagnosis of M. tuberculosis Infection

por Aggerbeck, Henrik, Giemza, Rafaela, Joshi, Paulatsya, Tingskov, Pernille N., Hoff, Søren T., Boyle, Julia, Andersen, Peter, Lewis, David J. M.
Publicado 2013

First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent

por Bergstedt, Winnie, Tingskov, Pernille N., Thierry-Carstensen, Birgit, Hoff, Søren T., Aggerbeck, Henrik, Thomsen, Vibeke O., Andersen, Peter, Andersen, Aase B.
Publicado 2010

Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls

por Zewdie, Martha, Howe, Rawleigh, Hoff, Søren T., Doherty, T. Mark, Getachew, Nahom, Tarekegne, Azeb, Tessema, Bamlak, Yamuah, Lawrence, Aseffa, Abraham, Abebe, Markos
Publicado en Tuberculosis (Edinb) (2016)

The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders

por Michelsen, Sascha Wilk, Soborg, Bolette, Diaz, Lars Jorge, Hoff, Soren Tetens, Agger, Else Marie, Koch, Anders, Rosenkrands, Ida, Wohlfahrt, Jan, Melbye, Mads
Publicado en PLoS One (2017)

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

por Zinman, Bernard, Aroda, Vanita R., Buse, John B., Cariou, Bertrand, Harris, Stewart B., Hoff, Søren Tetens, Pedersen, Karen Boje, Tarp-Johansen, Mads Jeppe, Araki, Eiichi
Publicado en Diabetes Care (2019)

C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial

por Aggerbeck, Henrik, Ruhwald, Morten, Hoff, Søren T., Borregaard, Bettine, Hellstrom, Elizabeth, Malahleha, Mookho, Siebert, Mirna, Gani, Mashra, Seopela, Vincent, Diacon, Andreas, Lourens, Madeleine, Andersen, Peter, Dheda, Keertan
Publicado en PLoS One (2018)

Development of a One-Step Probe Based Molecular Assay for Rapid Immunodiagnosis of Infection with M. tuberculosis Using Dried Blood Spots

por Blauenfeldt, Thomas, Heyckendorf, Jan, Graff Jensen, Sidse, Lange, Christoph, Drabe, Camilla, Hermansen, Thomas S., de Thurah, Lena, Lillebaek, Troels, Eugen-Olsen, Jesper, Seersholm, Niels, Hoff, Søren, Bonde, Jesper, Ruhwald, Morten
Publicado 2014

Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4(+) T Cells

por Lenz, Nicole, Schindler, Tobias, Kagina, Benjamin M., Zhang, Jitao David, Lukindo, Tedson, Mpina, Maxmillian, Bang, Peter, Kromann, Ingrid, Hoff, Søren T., Andersen, Peter, Reither, Klaus, Churchyard, Gavin J., Certa, Ulrich, Daubenberger, Claudia A.
Publicado en Clin Vaccine Immunol (2015)

A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area

por Hussein, Jemal, Zewdie, Martha, Yamuah, Lawrence, Bedru, Ahmed, Abebe, Markos, Dagnew, Alemnew F., Chanyalew, Menberework, Yohannes, Asfawesen G., Ahmed, Jemal, Engers, Howard, Doherty, T. Mark, Bang, Peter, Kromann, Ingrid, Hoff, Søren T., Aseffa, Abraham
Publicado en Trials (2018)

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6

por Ruhwald, Morten, de Thurah, Lena, Kuchaka, Davis, Zaher, Mostafa Rafaat, Salman, Ahmed M., Abdel-Ghaffar, Abdel-Rahman, Shoukry, Faten Aly, Michelsen, Sascha Wilk, Soborg, Bolette, Blauenfeldt, Thomas, Mpagama, Stellah, Hoff, Søren T., Agger, Else Marie, Rosenkrands, Ida, Aagard, Claus, Kibiki, Gibson, El-Sheikh, Nabila, Andersen, Peter
Publicado en Sci Rep (2017)

Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm(3): A Phase II, Multi-Centre,...

por Reither, Klaus, Katsoulis, Lynn, Beattie, Trevor, Gardiner, Nicolene, Lenz, Nicole, Said, Khadija, Mfinanga, Elirehema, Pohl, Christian, Fielding, Katherine L., Jeffery, Hannah, Kagina, Benjamin M., Hughes, Elisabeth J., Scriba, Thomas J., Hanekom, Willem A., Hoff, Søren T., Bang, Peter, Kromann, Ingrid, Daubenberger, Claudia, Andersen, Peter, Churchyard, Gavin J.
Publicado en PLoS One (2014)

Antigen availability shapes T cell differentiation and function during tuberculosis

por Moguche, Albanus O., Musvosvi, Munyaradzi, Penn-Nicholson, Adam, Plumlee, Courtney R., Mearns, Helen, Geldenhuys, Hennie, Smit, Erica, Abrahams, Deborah, Rozot, Virginie, Dintwe, One, Hoff, Søren T., Kromann, Ingrid, Ruhwald, Morten, Bang, Peter, Larson, Ryan P., Shafiani, Shahin, Ma, Shuyi, Sherman, David R., Sette, Alessandro, Lindestam Arlehamn, Cecilia S., McKinney, Denise M., Maecker, Holden, Hanekom, Willem A., Hatherill, Mark, Andersen, Peter, Scriba, Thomas J., Urdahl, Kevin B.
Publicado en Cell Host Microbe (2017)